Pomalidomide, Ixazomib, and Dexamethasone With or Without Intensification by Cyclophosphamide in Relapsed or Refractory Multiple Myeloma

NCT03731832 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Refractory Multiple Myeloma

Interventions

DRUG: MLN9708
DRUG: Pomalidomide 4 MG Oral Capsule
DRUG: Dexamethasone
DRUG: Cyclophosphamide

Sponsor

GWT-TUD GmbH